# Coadministration of GA2 Sporozoites With Adjuvants

> **NCT05468606** · EARLY_PHASE1 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 45 (estimated)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** GA2
- **BIOLOGICAL:** BCG
- **BIOLOGICAL:** YF-17D (fractional ID dose)
- **DRUG:** Imiquimod
- **OTHER:** Mock immunization

## Key facts

- **NCT ID:** NCT05468606
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-03
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05468606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05468606, "Coadministration of GA2 Sporozoites With Adjuvants". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05468606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*